Clinical response to methylphenidate in children diagnosed with attention-deficit hyperactivity disorder and comorbid psychiatric disorders (Q43059973)

13 November 2017

title

Clinical response to methylphenidate in children diagnosed with attention-deficit hyperactivity disorder and comorbid psychiatric disorders (English)

1 reference

attention deficit hyperactivity disorder

13 November 2017

1 reference

1 reference

Mariam Ter-Stepanian

1 reference

13 November 2017

Natalie Grizenko

series ordinal

1 reference

13 November 2017

Michael Zappitelli

series ordinal

1 reference

13 November 2017

Ridha Joober

series ordinal

1 reference

13 November 2017

language of work or name

English

0 references

publication date

1 May 2010

1 reference

Canadian Journal of Psychiatry

13 November 2017

published in

1 reference

13 November 2017

1 reference

13 November 2017

1 reference

13 November 2017

page(s)

305-312

1 reference

Correlates of comorbid psychopathology in children with ADHD.

13 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500506

National trends in the prevalence of attention-deficit/hyperactivity disorder and the prescribing of methylphenidate among school-age children: 1990-1995.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500506

Introduction--ADHD comorbidity and treatment outcomes in the MTA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500506

ADHD comorbidity findings from the MTA study: comparing comorbid subgroups

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500506

Assessment and treatment of attention deficit hyperactivity disorder in children with comorbid psychiatric illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500506

Comorbidity moderates response to methylphenidate in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500506

Variations in pharmacotherapy for attention deficit hyperactivity disorder in managed care

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500506

Effect of anxiety on cognition, behavior, and stimulant response in ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500506

Differential stimulant response on attention in children with comorbid anxiety and oppositional defiant disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500506

NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500506

Continuous performance test performance in a normative epidemiological sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500506

Factor structure of the restricted academic situation scale: implications for ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500506

Relationship between response to methylphenidate treatment in children with ADHD and psychopathology in their families

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500506

Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500506

The effect of methylphenidate on oppositional defiant disorder comorbid with attention deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500506

Methylphenidate in children with oppositional defiant disorder and both comorbid chronic multiple tic disorder and ADHD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500506

Estimating the economic burden of depression in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500506

Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500506

Anxiety and depression symptoms and response to methylphenidate in children with attention-deficit hyperactivity disorder and tic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500506

Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500506

Comorbidity as a predictor and moderator of treatment outcome in youth with anxiety, affective, attention deficit/hyperactivity disorder, and oppositional/conduct disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500506

Evidence-based pharmacotherapy for attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F070674371005500506

10.1177/070674371005500506

21 January 2018

Identifiers

DOI

1 reference

13 November 2017

1 reference